World Vapers’ Alliance
World Vape Day 2025 Marks 20 Years of Tobacco Harm Reduction Progress
World Vape Day 2025 Marks 20 Years of Tobacco Harm Reduction Progress
BRUSSELS, May 30, 2025 (GLOBE NEWSWIRE) -- Today, the global vaping community celebrates World Vape Day 2025, highlighting two decades of innovation and scientific advancement in tobacco harm reduction. This year’s theme, “20 Years of Facts”, underscores the growing body of evidence supporting vaping as a less harmful alternative to smoking and its role in helping millions of adults quit combustible tobacco.
World Vape Day is celebrated one day before World No Tobacco Day, emphasising the importance of evidence-based harm reduction tools in the fight against smoking-related disease. Since the introduction of modern vaping devices in 2003 and their subsequent arrival and uptake in Europe and the US, vaping has become a cornerstone of smoking cessation worldwide.
Countries such as Sweden, the UK, and New Zealand, which have embraced tobacco harm reduction policies and ensured access to regulated vaping products, now report record-low smoking rates. Sweden, for example, is poised to become the first smoke-free country in Europe, defined as having fewer than 5% daily smokers—an achievement attributed to widespread acceptance of safer nicotine alternatives. In contrast, nations with restrictive policies continue to lag behind in reducing smoking prevalence.
Despite robust scientific consensus, misinformation and regulatory barriers persist. Many health advocates warn that bans and flavour restrictions risk reversing progress by pushing former smokers back to cigarettes. “Persistent misperceptions about the relative risks of vaping versus smoking remain a significant challenge, with studies showing that a majority of smokers in many countries still believe vaping is as harmful or more harmful than smoking,” commented Michael Landl, Director of the World Vapers’ Alliance.
World Vape Day is a reminder for policymakers, public health officials, and the media to prioritise facts over fear and to recognise the real-world impact and potentials of harm reduction. Advocates stress that an inclusive, evidence-based approach is essential to accelerate progress towards global smoke-free goals and to ensure that adult smokers have access to effective alternatives.
For more information, campaign resources, and a full list of 20 facts about vaping and harm reduction, visit https://worldvapersalliance.com/world-vape-day/.
Media Contact:
Michael Landl
World Vapers’ Alliance
info@worldvapersalliance.com
worldvapersalliance.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7c5dd147-1785-4bb0-8249-4ab534f51783

Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
F. Hoffmann-La Roche Ltd31.5.2025 14:05:00 CEST | Press release
New data show Roche’s Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancer
Ipsen Pharma31.5.2025 14:00:00 CEST | Press release
Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma
WithSecure Oyj31.5.2025 08:45:00 CEST | Press release
WithSecure has completed the transaction of Cyber security consulting divestment to Neqst
Teva Pharmaceutical Industries Ltd31.5.2025 03:05:00 CEST | Press release
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
Teva Pharmaceutical Industries Ltd31.5.2025 03:00:00 CEST | Press release
Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TEV-'749 (olanzapine) to Date
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom